Faculty Sponsor

Jana Stedman

College

Nursing

Department/Program

Physician Assistant Program

Presentation Type

Poster Presentation

Symposium Date

Summer 7-24-2024

Abstract

Objective: To determine the effectiveness between topiramate and botulinum toxin type A in the prevention of chronic migraine and if there is a superior treatment option between the two. Migraines are a debilitating condition worldwide and determining the most effective treatment can help patients who suffer from them. Methods: Online databases were used to find academic sources that compared the use of topiramate and botulinum toxin type A. Only sources published within the last 5 years were included in this research paper. Results: Both topiramate and botulinum toxin type A were effective in decreasing monthly migraines, but botulinum toxin type A was slightly more effective. Topiramate had more adverse effects when compared to its counterpart, making the treatment option less tolerable. Conclusion: Because of the frequent adverse effects that result from topiramate, botulinum toxin type A is the superior treatment in the prevention of chronic migraine.

Keywords: chronic migraine, adults, prophylaxis, topiramate, botulinum toxin type A

Biographical Information about Author(s)

Madeline Aldrich has a special interest in surgery and plans on earning her Doctorate in Medical Science through Butler University following graduation. She will be presenting on “Botulism Toxin Type A injections compared to Topiramate in Prevention of Migraines” because she has a special interest in the various treatment options for the condition that affects people worldwide.

Download

Share

COinS